Author

Robert A. Svoboda

University of Nebraska Medical CenterORCID 0009-0003-6004-0768Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Benjamin Jacob DrapkiniD· 1 shared Chaitra RaoiD· 1 shared Deepan ChatterjeeiD· 1 shared Dianna H. HuismaniD· 1 shared Heidi M. VieiraiD· 1 shared James W. AskewiD· 1 shared Kurt W. FisheriD· 1 shared Robert E. LewisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Benjamin Jacob DrapkinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Cancer ResearchPeer-reviewedFeb 10, 2025

KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistance

Deepan Chatterjee, Robert A. Svoboda, Dianna H. Huisman…·Robert E. Lewis

This study identifies KSR1 as a critical regulator of SCLC tumor initiation and cisplatin resistance, showing that its disruption enhances cisplatin toxicity and reduces tumor-initiating cells.

10 citations

humangenetic perturbation / CRISPR

𝕏 PostBluesky